Moderna
Moderna, Inc., is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule... Wikipedia
- Formerly called: ModeRNA Therapeutics, (2010–2018)
- Type: Public
- Traded as: NASDAQ: mrna MRNA, Nasdaq-100 component, S&P 500 component
- ISIN: [ US60770K1079]
- Industry: Biotechnology
- Founders: Derrick Rossi, Timothy A. Springer, Robert S. Langer, Kenneth R. Chien, Noubar Afeyan
- Key people: Stéphane Bancel, CEO, Stephen Hoge, President, David Meline, CFO, Noubar Afeyan, Chairman, Robert S. Langer, Director, Paul Sagan, Director
- Products: SpikeVax, Vaccine candidates
- Revenue: US$803 million (2020)
- Operating income: US$ −763 million (2020)
- Total assets: US$7.336 billion (2020)
- Total equity: US$2.561 billion (2020)
- Owner: Noubar Afeyan (12.7%), Stéphane Bancel (7.9%), Robert S. Langer (2.9%), Stephen Hoge (1.3%)
- Number of employees: 2,500 (2021)
- Website: modernatx.com
- Data source: DuckDuckGo